Affiliation:
1. Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh,
India
Abstract
Abstract:
Radiation treatment has been advancing ever since the discovery of X-rays in 1895.The goal of radiotherapy is to shape the best isodose on the tumor volume while preserving normal tissues. There are three advantages: patient cure, organ preservation, and cost-effectiveness. Randomized trials in many various forms of cancer (including breast, prostate, and rectum) with a high degree of scientific proof confirmed radiotherapy's effectiveness and tolerance. Such accomplishments, which are critical to patients' quality of life, have been supported in the past. Radiopharmaceuticals were developed for the diagnosis and therapy of a variety of disorders, hyperthyroidism, bone discomfort, cancer of the thyroid gland, and other conditions like metastases, renal failure, and myocardial infarction and cerebral perfusion. It is also possible to sterilize thermo-labile materials with the radioactive substance. This includes surgical dressings and a wide range of other medical supplies. Nuclear medicine provides various advantages, including tumor localization, safe diagnosis, no radiation buildup, and excellent treatment effectiveness. Nowadays, the field of nuclear pharmacy is focused on developing novel radioactive pharmaceutical substances that will be useful.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Radiology, Nuclear Medicine and imaging
Reference135 articles.
1. Nadugopal B.; Swain S.S.; Ojha S.K.; Meher C.P.; Impact of radiopharmaceuticals in healthcare system. PharmaTutor
2017,5(8),23-31
2. Heske S.M.; Hladik W.B.; Laven D.L.; Kavula M.P.; Status of radiologic pharmacy education in colleges of pharmacy. Am J Pharm Educ 1996,60(2),152-161
3. Skanjeti A.; Miranti A.; Delgado Y.G.M.; Bianciotto D.; Trevisiol E.; Stasi M.; Podio V.; A simple and accurate dosimetry protocol to estimate activity for hyperthyroidism treatment. Nucl Med Rev 2015,18(1),13-18
4. Nakagawa Y.; Mori K.; Hoshikawa S.; Ozaki H.; Ito S.; Yoshida K.; Development of subclinical hyperthyroidism due to Graves’ disease in a hypothyroid woman who had undergone hemithyroidectomy for adenomatous goiter and radiotherapy for nasopharyngeal cancer. Endocr J 2007,54(1),35-37
5. Paes F.M.; Serafini A.N.; Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain. Semin Nucl Med 2010,40,89-104
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献